DOXFX | RRIGX | DOXFX / RRIGX | |
Total Expense Ratio | 0.52 | 1.33 | 39% |
Annual Report Gross Expense Ratio | 0.57 | 1.33 | 43% |
Fund Existence | 3 years | 23 years | - |
Gain YTD | 7.976 | 13.254 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 51.5B | 13.3B | 387% |
Annual Yield % from dividends | 2.15 | 1.86 | 116% |
Returns for 1 year | 8.72 | 14.77 | 59% |
Returns for 3 years | N/A | 35.16 | - |
Returns for 5 years | N/A | 113.47 | - |
Returns for 10 years | N/A | 52.46 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 19.65 | 0.70 | +3.69% |
ProShares UltraShort Nasdaq Biotech | |||
IGOV | 40.53 | 0.84 | +2.12% |
iShares International Treasury Bond ETF | |||
AGRH | 25.87 | -0.06 | -0.22% |
iShares Interest Rt Hdg U.S. Aggt Bd ETF | |||
XPH | 40.69 | -1.51 | -3.58% |
SPDR® S&P Pharmaceuticals ETF | |||
SMLF | 59.07 | -4.48 | -7.05% |
iShares U.S. Small-Cap Eq Fac ETF |